Cerba Research Netherlands B.V.
Rotterdam - Zuid-Holland
www.viroclinics.com
Naam
Cerba Research Netherlands B.V.
Sector
Activiteiten van financiële holdings
Werkenden
5-9 wn.
Adres
Adres verborgen. Dit bedrijf wil geen ongevraagde postreclame of verkoop aan de deur.
Postcode
3029AK
Plaatsnaam
Rotterdam
0 1 10 11 12 13 2 2018 2025 2026 22 26 3 30 4 400 42 50 6 8 a aav9 about accelerat accept acros action adc adoptiv advanc advances all allow also an analys and another anti antibody antigen antiviral application approach april are areas as asking aspect assay at back background becaus becom behaviour behind best big biomarker blog boundaries breakthrough breast bring built but by can cancer car car-t carer cas catalog cell center central centralized cerba cerbaresearch.com challenges circulatory clinical cod comes committed community company compared complex compromis condition conduct conjugates connect consistent constantly contact continent cookie cookies coordination copyright corporat courag covered curiosity customiz customized cytometry cytotoxic databases decad decades defin deliver delivered delivery design develop development diagnostic directly discover discus diseas diseases diving dna don driv drives driving drug each early edition efficacy engagement enhanc environmental ethical event every excellenc excit experienc expert expertis exploit explor faster fcm field find fiv flow focus follow for from frα futur gen general generat genomic get giving global globally goal going guid happ hav having healthcar healthier healthy help her her2 how if illuminat immun immunization immuno immunoassay immunogenicity immunology immunotherapy impact improv includ industry infectious infectives inflammation info@cerbaresearch.com innovation insight integrated integrates into it jun just key knowledg lab laboratories laboratory landscap last latest leadership leading learn legacy let leverag lif lik linkedin location management map matter may medicin met metabolic min mission mor most mutant napi2b ned network neurology new next ngs notic on oncology one ongoing optimal optimiz or order our out outsourc ovarian overcom overexpression panel part particular partner passiv pathogenicity patient paulo per personalized perspectiv pharmacokinetic phas phases planet plus poli
Vind meer informatie over Cerba Research Netherlands B.V. in de interactieve versie